Sudden cardiac death (SCD) is a devastating event in athletes. Screening efforts that were first directed at athletes younger than 35 years are now focusing on the rapidly growing group of older sportspersons. Athletes aged ≥35 years have a 10-fold increased risk of exercise-related cardiac arrest, mostly due to coronary artery disease (CAD). Although cardiac imaging is pivotal in identifying CAD, the role of imaging modalities in screening asymptomatic older sportspersons remains unclear. We performed a scoping review to identify the role of cardiac imaging to detect CAD in older sportspersons and to identify gaps in the existing literature. We searched MEDLINE, EMBASE and the Cochrane library for studies reporting data on cardiac imaging of CAD in sportspersons ≥35 years. The systematic search yielded 1737 articles, and 14 were included in this scoping review. Imaging modalities included two echocardiography, one unenhanced computed tomography (CT) for coronary artery calcium scoring (CACS), three CACS and contrast-enhanced CT angiography (CCTA), two CACS and cardiac magnetic resonance (CMR), one CCTA with CMR and echocardiography, two CCTA, two CMR, and one myocardial perfusion imaging article. The low number of relevant articles and the selection bias introduced by studying specific groups, like veteran marathon runners, indicate the need for future research. Cardiac CT (CACS and CCTA) probably has the highest potential for preparticipation screening, with high diagnostic value to detect CAD and low radiation dose. However, currently there is insufficient evidence for incorporating routine cardiac imaging in the pre-participation screening of asymptomatic sportspersons over 35 years.
of sudden cardiac death (SCD) in athletes aged 35 years and older, accounting for almost 90% of all cardiac deaths. 1, [4] [5] [6] Even in athletes aged 25 to 35 years CAD accounted for 43% of deaths in a recent U.S. study. 8 The traditional view that exercise-induced acute coronary events result from atherosclerotic plaque disruption and coronary thrombosis 4, [9] [10] [11] was recently challenged by a study of cardiac arrests during long-distance running. 2 The absence of coronary plaque rupture in many victims suggests there may be a causal role for demand ischemia in athletes with (unknown) CAD. 2 Consequently, it seems wise to aim at early identification of CAD in the pre-participation evaluation of sportspersons aged 35 years and older. To date, traditional cardiovascular (CV) risk scores, like the Framingham Risk Score (FRS) and European Society of Cardiology (ESC) Systematic COronary Risk Evaluation (SCORE), as well as resting and exercise electrocardiography (ECG), are used to identify athletes with a high risk of exercise-related cardiac events. 12 The use of CV risk scores and (exercise) ECG in athletes has limitations. CV risk scores may underestimate the risk in athletes, as these scores were not designed for physically active people. Regular exercise favorably influences CV risk factors by reducing weight and blood pressure and improving the lipid profile, and the resulting lower CV risk scores may provide a false sense of security. 13 Maximal exercise testing for CV evaluation of middle-aged individuals engaged in leisure-time sports activities is recommended by the ESC 12 and is now frequently part of a sports medical evaluation. Although the information on cardiorespiratory fitness is relevant for subsequent training programs, both the resting and exercise ECG are of limited value to detect occult CAD because of their low sensitivity in asymptomatic subjects with low and intermediate CV risk. 14, 15 The role of imaging modalities in the prevention of sportsrelated CV events in older sportspersons is only beginning to be addressed. This paper provides a scoping review of studies that have evaluated cardiac imaging to detect CAD in asymptomatic sportspersons aged 35 years and older and demonstrates both the potential of cardiac imaging and the knowledge gaps.
| METHODS
The scoping review was guided by Aksey and O'Malley's methodological framework that was refined by Levac and colleagues: "identifying the research question, searching for relevant studies, selecting studies, charting the data and collecting and reporting the results". 16, 17 We chose to perform a scoping review because of the absence of randomized controlled trials and to summarize the breadth of available evidence with different imaging modalities in this field. A scoping study design is ideal for incorporating a range of studies, and despite several similarities to a systematic review, it does not typically involve quality assessment, and therefore, we report findings in a narrative format.
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| The research question
We performed unrestricted searches in MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials, which identified relevant articles to answer our research question: "What imaging studies have been conducted on identification of CAD in sportspersons aged ≥35 years and what were the outcomes of these studies?". Searches were performed in February 2017 using a combination of the following terms: coronary artery disease, CV evaluation, athletes, middle-aged, and imaging. We included studies of middle-aged sportspersons engaged in non-professional competitive or recreational leisure sports who were screened for CAD including all possible imaging modalities. The search was expanded by reviewing references found in the manuscripts. The full search strategy is available in a Appendix S2 (e-Appendix 1). Searches were performed without language or publication restrictions.
| Outcome measures and definitions of CAD
Various imaging modalities can be used to identify CAD. These modalities are either modalities that visualize coronary anatomy for coronary calcification and luminal stenosis or functional tests that detect inducible myocardial ischemia perfusion abnormalities or wall motion abnormalities with exercise stress or intravenous pharmacological stress. Commonly used pharmacological agents are adenosine, dipyridamole or regadenoson (vasodilator stress), and dobutamine (inotropic).
Echocardiography can only indirectly identify CAD by
demonstrating segmental wall motion abnormalities either at rest or during exercise stress or alternatively pharmacological stress if patients are unable to exercise adequately.
2.
Cardiac CT provides direct information on the presence and extent of CAD: a. CACS: the coronary calcium burden is graded according to Rumberger et al, 18 in the following categories:
Agatston score 0 (no coronary calcium), 1-10 (minimal), 11-100 (mild), 101-400 (moderate), and >400 (extensive coronary calcium 
| Article selection
Electronic search results were downloaded into EndNote bibliographic software, Thomson Reuters, Philadelphia, United States. Two authors (TB and MW) independently screened titles and abstracts identified by the electronic search and applied the selection criteria to potentially relevant papers. Differences were resolved by consensus between these authors. Data, including aims, imaging modality, study populations, outcome measures, and important results, were entered onto a "data charting form" using Excel, Microsoft, Redmond, United States.
| Reporting the results
Of 1737 citations identified after searching MEDLINE, EMBASE, and Cochrane with the above search terms, 11 papers were selected for full-text reading. References of these 11 manuscripts and the personal database of one author (SS) were reviewed for potentially relevant manuscripts, identifying another three articles, and yielding a total of 14 articles, 13, 14, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] which were included in the current review. A flow chart of study inclusions is provided in Appendix S1.
| RESULTS
The search identified 14 original manuscripts, the characteristics of which are summarized below. Details of individual studies are shown in Table 1 . Table 2 demonstrates the advantages, costs, and diagnostic accuracy of the available imaging modalities compared to the non-imaging functional exercise test (X-ECG). Figure 1 demonstrates the gap in the existing literature and indicates where future research is necessary.
| Study characteristics
All articles were published in peer-reviewed journals, between 1998 and beginning 2017, and sample sizes ranged from 19 to 318 subjects. Five studies related to the same German male cohort of 108 marathon runners. 13, 21, 25, 27, 28 Populations in the other papers were 19 Scottish veteran endurance athletes, 22 Table 1 demonstrates the used imaging modalities: echocardiography only (n = 2), unenhanced CT for CACS (n= of 1), CACS combined with contrast-enhanced CCTA (n = 3), CACS combined with CMR imaging (n = 2), CCTA only (n = 2), CCTA with CMR and echocardiography (n = 1), CMR alone (n = 2), and MPS (n = 1).
| Echocardiography
No echocardiographic study focused on detection of CAD with exercise or pharmacological stress echocardiography. The only two echocardiographic imaging studies show the limited additional value of routine echocardiography to identify CAD. Aagaard et al 20 described the yield of routine echocardiography in 153 middle-aged men (mean age 51 ± 5 years) before first participation in a cross-country race. Preparticipation evaluation consisted of medical history, physical examination, ECG, ESC risk SCORE, and routine echocardiography. No exercise test was performed. Although the 10-year fatal CV risk was low (SCORE 1%, interquartile range 0%-1%), 14 (9%) runners required further workup, of which 12 were identified by ECG and only two were identified by echocardiography. Echocardiography revealed a tumor attached to the tricuspid leaflet, which was a lipoma on surgery, and mild aortic regurgitation at rest in another participant, who was cleared for participation after exercise stress echocardiography. Four runners (2%) were discouraged from vigorous exercise due to QTc intervals >500 ms in two subjects, symptomatic atrio-ventricular block in one subject, and the participant with the cardiac tumor before surgery. The authors concluded that physical examination with a 12-lead ECG was probably most effective in identifying those requiring additional workup, although they also stated that detection of CAD was limited by the absence of a reliable screening tool. Routine blood testing and echocardiography had no substantial additional value. 
| Coronary artery calcium scoring
Möhlenkamp et al 13, 27 , Kroger et al 25 CV risk in athletes. After 6 years of follow-up, seven runners experienced a coronary event, four of which during physical exercise but not related to a marathon, and one died from an acute coronary event. 27 The event rate in runners with CACS <100, 100-399, and ≥400 AU was 1. 
| Cardiac magnetic resonance imaging
No CMR studies administered adenosine or dobutamine for ischemia detection. Nassenstein et al 28 assessed left ventricular volumes (LV) and myocardial mass on CMR in the German marathon group in relation to conventional risk factors and coronary atherosclerotic burden (CACS). After initial increase in LV end-diastolic volume (LV-EDV) with age, LV-EDV decreases after 55 years of age. Although LV mass increased with increasing LV-EDV and blood pressure, runners with a LV mass ≥150 grams had significant higher CACS than those with LV mass <150 grams, median CACS 110 vs 25, P = .04. They conclude that myocardial mass depends on adaptation to sport, age and blood pressure, but unbalanced increase in LV wall mass may also be a subclinical response to risk factor exposure. Several studies reported on the role of LGE on CMR in 102 of the 108 German male marathon runners (mean age 57 ± 6 years). The extent of coronary atherosclerosis (CACS) and the number of completed marathons were both associated with myocardial fibrosis, as shown by LGE on CMR. Breuckmann et al 21 compared the prevalence of myocardial distribution of LGE in these male marathon runners with asymptomatic control subjects and examined the prognostic role of LGE. They concluded that these seemingly healthy marathon runners have an unexpectedly high rate of myocardial LGE, 12% vs 4% in controls, P = .077, and event-free survival was lower in those with myocardial LGE compared to those without P < .0001. Two LGE patterns emerged: a CAD pattern with subendocardial or transmural distribution and a non-CAD (non-ischemic) pattern with mid-myocardial or epicardial distribution. Marathon runners with prevalent myocardial fibrosis on baseline also developed higher highsensitive serum troponin I values during the race, but unlike CACS and LGE, higher troponin I values were not associated with future coronary events. 27 It was unclear from the German Marathon Study whether the increased LGE occurred because of repeated marathon running or due to occult CAD. Karlstedt et al 24 performed a more extensive examination in a small group of 25 marathon runners (age 55 ± 4 years, 84% men) from the 2010 and 2011 Manitoba Full Marathons who had participated in at least three marathons in the past 2 years. Extent and severity of cardiac dysfunction after a complete marathon was assessed using cardiac biomarkers and echocardiography, 1 week before, immediately after and 1 week after the marathon, CMR, before and within 24 hours after the marathon, and coronary CT angiography within 3 months of the marathon. All participants demonstrated a transiently elevated troponin T and RV dysfunction post-marathon. Only two participants had a subendocardial ischemic pattern of LGE of the anterior wall of the left ventricle with evidence of a significant stenosis of the left anterior descending artery on coronary CT angiography. It is unknown if these two participants underwent subsequent ischemia testing or catheter angiography. Mangold et al 26 performed CMR imaging in 95 endurance athletes aged 18-62 years (mean age 35.2 ± 11.4 years, 87% male, 81% long-distance runners, cyclists, or triathletes). The 50-minute CMR examination included cine images, coronary MR angiography, and LGE. They reported abnormal findings in six (6%) athletes: two benign coronary anomalies, one dilated ascending aorta (42 mm), two patients with non-ischemic pattern of LGE, probably post-myocarditis, and one patient with pericardial and pleural effusion, but no wall motion abnormalities or LGE, which was probably virus-related and resolved on follow-up. They concluded that routine implementation of CMR imaging in the context of pre-participation screening cannot be recommended since the prognostic significance of these findings remains unclear.
| Myocardial perfusion scintigraphy
Katzel et al 23 compared prevalence of exercise-induced silent ischemia on ECG, ST-segment depression using Minnesota Code criteria, and perfusion abnormalities on thallium scintigraphy in 70 asymptomatic male athletes (aged 63 ± 6 years) and in 85 healthy untrained men (aged 61 ± 7 years) with no history of CAD, hypertension, or diabetes. The prevalence of exercise-induced single positive test, abnormal exercise electrocardiogram, or thallium scan, and silent ischemia, abnormal exercise electrocardiogram, and thallium scan, was similar in athletes and untrained men: 19% vs 18% and 16 vs 21%, respectively, P = .36. None of these asymptomatic men with silent ischemia underwent subsequent coronary catheterization. There was also no difference in incidence of coronary events: four athletes with silent ischemia and four non-athletes with silent ischemia and one non-athlete with a single positive test during seven-year follow-up.
| DISCUSSION
This scoping review identified 14 studies that used cardiac imaging to detect CAD in the rapidly growing group of older sportspersons. Our main findings are as follows: (a) a low number of relevant articles were published with small sample sizes and very few women (7%); (b) the studies were predominantly cross-sectional and mostly conducted in highly selected groups (eg, marathon runners); (c) a higher risk of coronary events in sportsmen with higher CACS and also a potentially higher coronary risk than anticipated on the basis of the (low) conventional cardiovascular risk scores; (d) a relatively high rate of myocardial LGE in marathon runners with a higher than anticipated risk of coronary/cardiac events in those with LGE. It should be noted that last two findings come from the same cohort. The major goal of the pre-participation evaluation of athletes over 35 years of age should be detection of relevant CAD, the most important cause of exercise-related cardiac events. 1, 5, 6 Family history of CV disease and medical history are of pivotal importance. CAD in athletes may not only present as typical angina but also as an unexplained decline in exercise performance, and one cannot base the assessment of elderly sportspersons solely on the current CV risk profile and exercise capacity. This scoping review focused on the different imaging techniques used to identify CAD in middleaged sportspersons and provides an overview of the gaps in literature and challenges for future research.
| Gaps in research
Most studies investigate habitual master endurance athletes (Figure 1) , thereby ignoring the large group of middle-aged recreational sportspersons, in whom by sheer magnitude most cardiac events will occur.
In addition, future studies should focus on important issues as age of presentation for screening (35-55, 55-75, >75 years), sex, the level of sports (leisure or elite sports), and the sports discipline. A lifetime sports-related risk score is necessary to assess which sportspersons require more workup and the precise nature of this assessment. Ideally, there would be a weighted score for exposure per decade for different risk factors. These risk factors include the traditional risk factors such as cholesterol, hypertension, diabetes, obesity, and smoking, as well as family history and personal history for periods of regular physical exercise or sedentary lifestyle.
Recent research 7 confirmed the striking lower incidence of exercise-related cardiac arrest in women by calculating the incidence rate or sports-related sudden death in France between 2005 and 2010 including a population of approximately 35 million inhabitants. The authors demonstrated that the overall average incidence rate in women was estimated to be 0.51 per million female sports participants vs 10.1 in men.
Although the observed sex differences may be attributed to lower sports participation rates in women, given the fact that the authors provided incidence per million participants, it is unlikely to explain such differences. Furthermore, the authors showed that the incidence rate of sports-related sudden death significantly increased with age among men, but not among women. A later onset of coronary artery disease in women could play a role; however, a greater risk of exercise-related OHCA per se in men cannot be excluded and this requires further research. Furthermore, the contrasting results between male and female long-term marathon runners 29, 30 probably have multifactorial causes, including gender and hormonal differences, differences in marathon running years (inclusion based on minimal of 10 years in women vs 25 years in men), and possibly differences in lifestyle. This requires further investigation.
| Challenges
The main challenge is to provide fast, reproducible, and easy to analyse information on CAD. Currently available noninvasive imaging techniques either evaluate cardiac function and anatomy (echocardiography, CMR), inducible myocardial ischemia (stress echocardiography, CMR, MPS) visualize CAD indirectly (wall motion abnormalities on echo and CMR, LGE on CMR) or directly (coronary calcium burden with CACS and luminal narrowing with CCTA). While these tests are relatively non-invasive compared to the reference standard (coronary catheterization), CT and MPS are also associated with radiation exposure and possible adverse effects, and costs pose a financial burden for screening asymptomatic sportspersons. Although echocardiography is the most widely available and cheapest non-invasive imaging technique, it probably has the least additional value in the older sportspersons to detect relevant CAD. In addition, finding abnormalities in asymptomatic persons with a normal ECG in whom no murmurs are heard on physical examination is unlikely. 32 MPS, although accurate, carries the highest costs and radiation exposure and is therefore not a realistic option for screening.
The most comprehensive imaging technique is CMR, with excellent, multiparametric information on biventricular function, volume and mass, accurate ischemia detection with adenosine stress, and myocardial fibrosis detection with LGE. 33 Myocardial fibrosis, especially with a CAD pattern, has predictive value for future events 21 but remains an indirect sign of CAD. In addition, it remains unclear whether this predictive value in the highly selected group of marathon runners can be translated to the recreational sportspersons. Non-ischemic patterns of myocardial fibrosis, especially in the intraventricular septum and near the hinge points between the right ventricle and septum, are seen relatively often in older athletes with a lifelong history of endurance sports. 34 CMR coronary angiography can detect coronary anomalies accurately, but is not yet robust enough to identify relevant CAD. The scan time, costs, limited availability of CMR for large-scale screening, and insufficient visualization of the coronaries make this a less practical screening method, especially in the field of recreational sports. Non-contrast cardiac CT for CACS provides a direct measure of CAD. It is the strongest independent predictor of CV events in asymptomatic persons and has been recommended as a first-line test over exercise testing in those with a low risk of CAD. 35, 36 Absence of coronary artery calcium (CAC) is associated with a very low risk of CV events in asymptomatic and symptomatic individuals. 37 Moreover, in a study employing both calcium scanning and stress testing in the same asymptomatic participants, the presence of calcified coronary atherosclerotic plaque conveyed increased risk of subsequent cardiac events in asymptomatics, even with a normal stress perfusion study. 38 The radiation dose is minimal (around 1 mSv, less than half the background radiation absorbed per year), and the scan time and costs are reasonably low compared to MRI and MPS, and even echocardiography. The low number needed to screen (NNS) (20) in the general population to identify an individual with moderate CAD, a CACS ≥100 AU, seems enough justification for extending CACS to lower risk individuals in future guidelines, as CAC is also associated with risk of CV events among individuals with few or no risk factors. 36 Recent radiation dose reductions (<1-3 mSv) combined with an excellent diagnostic accuracy for CAD, regardless of risk profile, make CCTA another viable option for screening sportspersons. 39 CCTA has additional value to CACS by visualizing the coronary lumen, and thereby enabling stenosis grading and evaluation of the total coronary atherosclerotic burden, including non-calcified plaque. This may be relevant in light of the concept that non-obstructive CAD, that is, demand ischemia, may play an important role in exercise-related cardiac events 2 but also in light of the concept that exercise-induced acute coronary events result from plaque rupture causing myocardial infarction, which was demonstrated in the study of Burke et al 9 They performed a study among 141 men with severe CAD, who died suddenly, and compared coronary arteries (with the aid of autopsy) between death during strenuous activity or emotional stress and death at rest. The 25 patients who died during exercise showed significantly more vulnerable plaques and plaque ruptures, compared with the 114 men who died at rest. CCTA is currently the only non-invasive diagnostic test that could establish the presence of a vulnerable plaque. As demonstrated, positive coronary vessel remodeling, low attenuation plaques, and spotty calcification are associated with subsequent occurrence of acute coronary syndrome 40, 41 Therefore, CCTA could be an additional screening tool for vulnerable plaque causing exercise-induced cardiac arrest.
To date, only one cross-sectional study demonstrated additional value of CACS and CCTA to exercise testing in asymptomatic sportsmen.
14 Agatston scores larger than 100 or >50% coronary stenosis were used as outcome, but whether CACS and CCTA in asymptomatic sportsmen improve management to prevent hard CV outcomes remains to be elucidated. A randomized study could investigate the hypothesis that the introduction of cardiac CT in the sports medical evaluation reduces the incidence of exercise-related cardiac events in older athletes. However, being able to perform a formal randomized trial of CACS or CCTA in older sportspeople is unlikely given the costs restraints from expected low event rates. Therefore, a registry may be a more realistic goal. Medical and family history, physical examination, and (exercise) ECG in combination with conventional CV risk scores still form the cornerstone of the sports medical evaluation of older sportspersons although this approach fails to reliably identify CAD. Colleagues from Italy provided the only largescale evaluation of exercise stress testing in pre-participation screening for competitive sports. Their study reported the results of over 30 000 referrals for screening with exercise ECG. The unselected population included a combination of welltrained athletes and non-athletes seeking to commence sport. Abnormalities were detected in 4.9% leading to disqualification from competitive sport in 0.6% of the total population. The efficacy of these exclusions in preventing SCD remains unknown. 42 However, Marijon et al 7 demonstrated in a large 12-year prospective study of sudden cardiac arrest (SCA) in a northwestern U.S. metropolitan region that sports-associated sudden cardiac arrest in middle age represents a relatively small proportion of the overall SCA burden. In addition, their findings of a high prevalence of established cardiovascular disease and symptoms that manifested in advance of SCA highlight a prevention gap that can potentially be closed. In addition, previous research from the Oregon region demonstrated that warning signs frequently occur in the days and weeks before a sudden cardiac arrest but are usually ignored. 43 Therefore, it appears prudent that asymptomatic athletes promptly search medical attention in case of warning symptoms such as chest pain or shortness of breath or unexplained deterioration of their condition. In contrast to the beneficial effect of moderate long-term exercise, intense long-term training may be associated with accelerated coronary atherosclerosis. Recent research 44 confirmed this hypothesis by demonstrating a higher prevalence of high (≥300 AU) CAC scores in a cohort of masters athletic men without established conventional risk factors for CAD who had engaged in several decades of endurance exercise compared with sedentary men of similar age and a similarly low atherosclerotic risk profile. Possible mechanisms include increased mechanical stress on the vessel wall-altering coronary artery flow dynamics and ultimately accelerating atherosclerosis with long-term (lifelong) exercise and elevated parathyroid hormone levels increasing circulating calcium values, which could accelerate the process of atherosclerosis. 45, 46 Cardiac imaging can contribute to the identification of CAD, but at this stage no firm recommendations can be made regarding the routine use of imaging studies in a sports medical evaluation setting. It is a matter of debate what steps should follow when cardiac imaging reveals asymptomatic CAD during a sports medical evaluation. Many practitioners feel that any degree of CAD on cardiac CT should be managed aggressively. The threshold for statin treatment to prevent CV events is becoming lower in recent guidelines. For example, by applying the recent ACC/AHA guideline to a European population aged 55 years or older, nearly all men (96.4%) would be eligible for statin treatment, compared to 66.1% when following the ESC guidelines. 47 One must also realize that sportspersons might suffer more from side effects of statin treatment, such as myalgia occurring in 5%-7%.
11,48

| PERSPECTIVES
This review demonstrated the gaps and challenges in the existing literature regarding imaging to detect CAD in middle-aged sportsmen. Most of the papers investigating the role of imaging to detect CAD in older athletes have been published in highly selected groups, like long-term male marathon runners. Relatively little is known about the other sport types and training levels, including the growing group of middle-aged recreational sportsmen and few papers evaluated CAD in older female athletes, while there are clear gender differences. This relatively low number of relevant articles indicates the need for future research on this topic, addressing the large group of recreational athletes (both men and women) rather than elite athletes.
Currently, there is insufficient evidence for incorporating routine cardiac imaging in the pre-participation screening of asymptomatic sportspersons over 35 years and more data are needed for different imaging modalities in this field. Therefore, prospective studies and larger observational studies with long-term follow-up are needed in this group to characterize the preventive value of cardiac imaging.
Cardiac CT (CACS and/or CCTA) may hold the best potential for use in pre-participation screening of older athletes, especially because the diagnostic value has increased considerably and the radiation dose is declining rapidly. In the future, efforts should be made to develop a randomized design or at least a registry to investigate whether the introduction of imaging, like cardiac CT in a sports medical evaluation setting, reduces the incidence of (exercise-related) cardiac events in this group and is cost-effective, compared to exercise testing.
ORCID
T. L. Braber
http://orcid.org/0000-0002-7571-5532
